Table: Kyorin Pharmaceutical -2024/25 parent results

Kyorin Pharmaceutical

12/05/2025 07:32

May 12 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          115.92          105.16         111.10        50.30    
               (+10.2 pct)                    (-4.2 pct)    (+3.6 pct) 
  Operating       12.90            6.89           6.30         2.10    
               (+87.2 pct)                    (-51.2 pct)   (+0.6 pct) 
  Recurring       13.71            7.63           6.80         2.40    
               (+79.6 pct)                    (-50.4 pct)   (-9.6 pct) 
  Net              9.38           53.14           5.10         1.80    
               (-82.3 pct)                    (-45.6 pct)   (-2.0 pct) 
  EPS          163.29 yen      925.92 yen      88.76 yen    31.33 yen  
  Ann Div       57.00 yen       52.00 yen      57.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen               
  -Q4 Div       37.00 yen       32.00 yen      37.00 yen               
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T